Summary by Futu AI
NexImmune, Inc. President and CEO, Kristi Jones, completed a purchase of the company's stock on June 11, 2024. The transaction involved the acquisition of 1 share of NexImmune's Series A Preferred Stock at a price of $0.01 per share. Following the transaction, Jones holds a total of 1 share in direct ownership. The transaction reflects the executive's confidence in the company and provides investors with a signal of potential future performance.